Home Healthcare Medical Devices Lithotripsy Devices Market

Lithotripsy Devices Market Size, Share & Trends Analysis Report By Type (Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices), By Applications (Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones), By End-User (Hospitals, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Lithotripsy Devices Market Size

The global lithotripsy devices market size was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.92 billion by 2034, registering a CAGR of 4.87% during the forecast period from 2026 to 2034. North America dominated the lithotripsy devices market with a market share of 36.4% in 2025.

The global incidence of urolithiasis is increasing, and this can be associated with a range of factors such as dietary habits, shifts in lifestyle, and demographic features. This is expected to drive the global lithotripsy device market. Moreover, due to its huge advantages, the rising demand for non-invasive or minimally invasive surgery is further fueling the global lithotripsy devices market growth.

Lithotripsy is a medical procedure employed to treat kidney stones and other urinary tract stones. Lithotripsy devices are medical instruments that have been specifically designed to perform lithotripsy. The etymology of the name "lithotripsy" can be traced back to its Greek origins, where "lithos" denotes stone and "tripsis" signifies the act of crushing. The objective of lithotripsy is to shatter kidney stones or other urinary stones into smaller particles, facilitating their natural expulsion from the body.

Although various varieties of lithotripsy devices exist, applying shock waves is a prevalent technique. The technique described is called extracorporeal shock wave lithotripsy (ESWL). Other types of lithotripsy, such as intracorporeal lithotripsy, may entail direct contact with the stone through specialized instruments. This may encompass methodologies such as laser lithotripsy, which utilizes a laser to fragment the stone, or ultrasonic lithotripsy, which employs high-frequency sound vibrations to accomplish the identical objective.

Lithotripsy Devices Market Size

Download a Free Sample To learn more about this report.

Type Insights

The global lithotripsy device market is bifurcated into extracorporeal shock wave and intracorporeal lithotripsy devices. The extracorporeal shock wave lithotripsy device segment dominates the global market. Extracorporeal Shock Wave Lithotripsy (ESWL) is a minimally invasive medical intervention employed to fragment kidney stones into smaller fragments, facilitating their passage via the urinary tract. The methodology entails the application of externally generated shock waves that are directed toward the kidney stones. The generation of shock waves is conventionally accomplished through an extracorporeal shock wave lithotripsy device.

In addition, specialized instruments are utilized for ESWL to generate and concentrate shock waves with extreme precision. These apparatuses frequently comprise a patient positioning device, a shock wave generator, and imaging technology to guide the procedure. The procedure must be carried out under the strict supervision of medical professionals who have received the appropriate training.

Lithotripsy Devices Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The global lithotripsy devices market is divided into kidney stones, ureteral stones, bile duct stones, and pancreatic stones. The kidney stone segment is the largest revenue contributor to the market. Kidney stones, sometimes called renal calculi, are solid concretions that develop within the renal system. Kidney stones form due to the heightened concentration and subsequent crystallization of chemicals such as calcium, oxalate, and phosphorus in the urine. The stones exhibit a range of sizes, spanning from minuscule grains of sand to enormous golf balls. The development of kidney stones is a multifaceted process that is impacted by a range of factors, encompassing genetic predisposition, dietary patterns, and hydration levels. Moreover, the development of kidney stones can be influenced by factors such as dehydration, specific medical disorders, and a diet that is rich in salt and certain minerals.

End-User Insights

The global lithotripsy devices industry is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment owns the highest market share. Hospitals can enhance awareness among patients and referring physicians regarding the availability and advantages of lithotripsy procedures. This, in turn, may result in more patients seeking lithotripsy treatment, thereby augmenting the demand for lithotripsy devices. Moreover, the growing number of hospitals across several countries positively impacts the demand for lithotripsy devices. For instance, as per the American Hospital Association Annual Survey 2021, in the United States, there were 1,805 rural community hospitals, 3,336 urban community hospitals, and 3,453 community hospitals in a system in 2019.

Lithotripsy Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global lithotripsy device market shareholder and is expected to expand substantially during the forecast period. North America is a developed region with advanced and smart healthcare services, excellent infrastructure, and a high adoption rate of advanced products, which drives market growth in the region. The primary factor driving the lithotripsy device market in the region is the surging prevalence of kidney stones.

  • For instance, according to UCI Health, the incidence of kidney stones in the American population has exhibited a significant two-fold increase in recent decades.

More than 10% of the United States population may encounter kidney stones at some point during their lifetime. Moreover, the U.S. has the highest per capita GDP of over USD 46,760 and per capita health expenditure of USD 7,720. This also drives the lithotripsy device market in North America.

Additionally, the increasing launch of new products and their approval by the key players in the market are also boosting market expansion.

  • For instance, in January 2022, Applaud Medical disclosed that its Acoustic Enhancer technology had been granted FDA breakthrough device designation.

Acoustic Enhancer technology, developed by Applaud Medical in San Francisco, is intended to integrate ureteroscopy with laser lithotripsy (URS-LL). Its purpose is to fragment calcium-based urinary stones (with a minimum diameter of 6mm and a maximum diameter of 20mm) that are obstructive or are determined by a urologist or other qualified physician to pose a substantial risk of future obstruction.

North America Lithotripsy Devices Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Lithotripsy Devices Market Trends

Europe is expected to expand at a significant rate. According to Eurostat data, the number of minimally invasive treatments increased in 20 of Europe's 21 member states from 2013 to 2018. The region's growing geriatric population is also encouraging the use of minimally invasive procedures. According to Eurostat, the proportion of the European population aged 65 and older has risen from 17.69% in 2010 to 20.69% in 2020. Therefore, this rise in the geriatric population and minimally invasive surgeries is driving the lithotripsy device market in the European region.

In addition, there has been a surge in regulatory approval for lithotripsy devices in the region.

  • For instance, in March 2021, Dornier MedTech (Dornier) won the distinction of being the inaugural integrated urology company globally to obtain certification under the new medical device regulation (MDR) of the European Union.

Dornier has received the MDR certification for two of its Class IIb products: the Dornier UIMSTM, a cutting-edge information management system that aids clinicians in the treatment of kidney stones, and the Dornier Delta® III, a highly effective lithotripter that leverages the company's Extracorporeal Shock Wave Lithotripsy (ESWL) technology. Such factors are anticipated to expedite market expansion in the region.

Asia Pacific Lithotripsy Devices Market Trends

In the Asia-Pacific, strong economic growth is expected to play a key role in the market's growth. The growth in the number of minimally invasive surgeries in the region is expected to be strongly driven by the huge population and increasing affordability among the rising middle class. This growth in preference for minimally invasive surgeries further drives the lithotripsy devices market. In addition, the advancement in lithotripsy technology further stimulates the expansion of the Asia-Pacific market.

  • For instance, in October 2020, the Department of Urology at Jipmer in Puducherry, India, commissioned an innovative extracorporeal shock-wave lithotripsy system, the Dornier Delta III. This state-of-the-art technology enables the department to provide non-surgical therapy for urinary stones.

List of Key and Emerging Players in Lithotripsy Devices Market

Zimmer MedizinSystems GmbH
Olympus Corporation
Boston Scientific Corporation
Richard Wolf GmbH
EDAP TMS
NOVAMEDTEK
Advin Health Care
STORZ Medical AG

Key Industry Developments

August 2025
Olympus Corporation continued strengthening its urology business through advancements in single-use and reusable endoscopic technologies designed for stone management procedures. The company focused on improving procedural efficiency through integrated visualization and lithotripsy workflow solutions.
July 2025
Richard Wolf GmbH expanded its endourology product offerings with enhanced ureteroscopy and lithotripsy-compatible visualization systems. The developments supported hospitals and surgical centers adopting minimally invasive kidney stone treatment approaches.
June 2025
Dornier MedTech announced advancements in its next-generation shock wave lithotripsy technology portfolio, focusing on improved stone fragmentation efficiency, treatment accuracy, and patient comfort. The company continued expanding its presence in extracorporeal shock wave lithotripsy (ESWL) solutions for urological care.
May 2025
Boston Scientific expanded its urology portfolio with continued commercialization of the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope and associated stone management solutions. The platform supported improved visualization and workflow efficiency during kidney stone procedures, strengthening the company’s position in minimally invasive lithotripsy technologies.

Report Scope

Segmentation

By Type 2
  • Extracorporeal Shock Wave Lithotripsy Devices
  • Intracorporeal Lithotripsy Devices
By Applications 4
  • Kidney Stones
  • Ureteral Stones
  • Pancreatic Stones
  • Bile Duct Stones
By End-User 3
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Zimmer MedizinSystems GmbH · Olympus Corporation · Boston Scientific Corporation · Richard Wolf GmbH · EDAP TMS
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The lithotripsy devices market size is valued at USD 1.31 Billion in 2026 and is projected to reach USD 1.92 Billion by 2034, at a CAGR of 4.87% during the forecast period 2026-2034.
North America dominated the market with a share of 36.4% in 2025.
The leading players in this market are Zimmer MedizinSystems GmbH, Olympus Corporation, Boston Scientific Corporation, Richard Wolf GmbH, EDAP TMS.
The lithotripsy devices market is projected to grow at a CAGR of 4.87% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now